Reaxa showcases Ni EnCat technology

By Phil Taylor

26-Nov-2008 - Last updated on 28-Sep-2021 at 09:13 GMT

Reaxa CEO Dr Peter Jackson explains why the firm added a nickel catalyst to its EnCat range.

Reaxa CEO Dr Peter Jackson explains why the firm added a nickel catalyst to its EnCat range.

Related news

Related products

show more

A Culture of Innovation as a Differentiation

Softigel by Procaps | 06-Dec-2021 | Product Presentation

We create safe, effective and differentiated pharmaceutical solutions and this has been our goal since day 1. The main driver of our growth is innovation...

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Seed Train Intensification Using High Cell Density Cryopreservation and Specially-designed Expansion Medium

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Technical / White Paper

Upstream processes can be intensified using a number of strategies which can deliver significant improvements in speed, flexibility and reliability. In...

Process Optimization and Scalability Evaluation of Pellicon® Capsules for Single-Pass Tangential Flow Filtration of mAb-Based Biomolecules

BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | Application Note

Single-pass tangential flow filtration (SPTFF) is a method of ultrafiltration for the purposes of either volume reduction or protein concentration. This...

Follow us

Products

View more

Webinars

On-demand webinars

Headlines

Promotional Features